Back to 
Candriam S.C.A.
Candriam S.C.A.
ELVN5 quarters
Position history for Candriam S.C.A.'s holdings in ENLIVEN THERAPEUTICS INC
Yes. Candriam S.C.A. holds 905,674 shares of ELVN (Enliven Therapeutics), worth $45.9M, as of its Q2 2026 13F filing. It increased the position by 311,595 shares (+52.5%) from Q1 2026. Candriam S.C.A. has held ELVN since Q2 2025, across 5 quarterly 13F filings. ELVN is 0.2% of Candriam S.C.A.'s reported 13F portfolio.
Current Value
$45.9M
Current Shares
905,674
Total Value Change
+$37.6M
Total Shares Change
+489,024
Quarter-by-Quarter History
Other major holders of ELVN: FMR LLC, Polar Capital Holdings Plc, BlackRock, Inc.